PCN100 Cost Utility Analysis of Bortezomib in a Biomarker Positive Subgroup of Relapsed and Refractory Folicular Lymphoma

✍ Scribed by S. Vandekerckhove; M. Lamotte; S. Iannazzo; O. Chirita

• Book ID: 119312385
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 62 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.2140